Pfizer

SEP 9, 2026 · PHASE 1/2 TRIAL

A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer

ClinicalTrials.gov

This is an active Phase 1/2 trial registration with no results posted; enrollment is complete but outcomes have not been reported in this registry record.

SEP 4, 2026 · PHASE 3 TRIAL

A Study to Learn About Safety and Effects of Once-weekly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JW)

ClinicalTrials.gov

This is a registered Phase 3 trial that has not yet recruited or reported results; the registry entry describes only the planned design and primary outcome measure, with no efficacy or safety data available.

SEP 4, 2026 · PHASE 1 TRIAL

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

ClinicalTrials.gov

This is a Phase 1 trial registration with no results posted; it describes planned enrollment and safety endpoints in an early-stage study of an investigational antibody-drug conjugate.

SEP 4, 2026 · PHASE 3 TRIAL

A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity

ClinicalTrials.gov

This is a registered Phase 3 trial not yet recruiting with no results posted; it represents a planned study with defined primary endpoints but no outcome data to evaluate.

AUG 20, 2026 · PHASE 2 TRIAL

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

ClinicalTrials.gov

This is a Phase 1/2A open-label, non-randomized safety and tolerability study of an investigational agent; no results are reported in this registry record.

AUG 20, 2026 · PHASE 2 TRIAL

A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

ClinicalTrials.gov

Phase 2 interventional trial with planned enrollment of 333 participants comparing PF-07220060 plus fulvestrant to physician's choice in HR+/HER2− advanced breast cancer; registry record reports no results yet.

AUG 20, 2026 · OBSERVATIONAL STUDY

A Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palbociclib Treatment Using a Real-world Database

ClinicalTrials.gov

This is a completed observational registry study with extremely limited enrollment (1 participant) examining real-world safety of palbociclib; results are not yet reported in this registry record.

AUG 17, 2026 · PHASE 2 TRIAL

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

ClinicalTrials.gov

This is a Phase 2 interventional trial registration with no results yet posted; it describes a planned study design and enrollment target only.